Search results
GSK plc (NYSE:GSK) Receives $47.00 Average Target Price from Brokerages
ETF DAILY NEWS· 9 hours agoShares of GSK plc (NYSE:GSK – Get Free Report) have received an average rating of “Moderate Buy” from the seven analysts that are covering the firm, Marketbeat ...
GSK plc (NYSE:GSK) Shares Acquired by First Hawaiian Bank
ETF DAILY NEWS· 4 days agoFirst Hawaiian Bank boosted its holdings in GSK plc (NYSE:GSK – Free Report) by 3.3% in the first quarter, according to the company in its most recent Form ...
Cwm LLC Cuts Stock Holdings in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 4 days agoCwm LLC trimmed its stake in shares of GSK plc (NYSE:GSK – Free Report) by 7.2% in the 1st quarter, according to its most recent disclosure with the SEC ...
9,154 Shares in GSK plc (NYSE:GSK) Bought by Virtu Financial LLC
ETF DAILY NEWS· 4 days agoVirtu Financial LLC acquired a new position in shares of GSK plc (NYSE:GSK – Free Report) in the fourth quarter, according to its most recent 13F filing ...
AI Regulation Must Not Stifle Growth, GSK CEO Says
Barrons.com· 4 days agoGSK is betting on AI to boost innovation for its pipeline as investor concerns cloud over the company's research-and-development productivity, but a...
Leo Wealth LLC Purchases New Shares in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 6 days agoLeo Wealth LLC purchased a new stake in GSK plc (NYSE:GSK – Free Report) during the 4th quarter, according to the company in its most recent filing with ...
NBC Securities Inc. Has $1.43 Million Stock Holdings in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 4 days agoNBC Securities Inc. trimmed its position in GSK plc (NYSE:GSK – Free Report) by 1.7% in the first quarter, according to the company in its most recent Form ...
GSK (LON:GSK) Given Underweight Rating at JPMorgan Chase & Co.
ETF DAILY NEWS· 5 days agoJPMorgan Chase & Co. reissued their underweight rating on shares of GSK (LON:GSK – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com ...
iTeos Therapeutics and GSK begin Phase III trial of combination therapy for NSCLC
Clinical Trials Arena via Yahoo Finance· 6 days agoiTeos Therapeutics and GSK have begun the GALAXIES Lung-301 Phase III clinical trial of belrestotug...
Industry groups back drugmakers' appeal in Zantac cancer lawsuits
Reuters via Yahoo News· 4 days agoA bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued...